Skip to main content
Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
44.27
-1.00 (-2.21%)
May 13, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Peptide Therapeutics
434.43M
Log In
Log In
Log In
Log In
Upgrade
Peptide Therapeutics Growth
624.05%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
434.43M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
624.05%
Log In
Log In
Log In
Log In
Upgrade